Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001829126-26-005672
Filing Date
2026-05-26
Accepted
2026-05-26 16:44:10
Documents
82
Period of Report
2025-12-31

Document Format Files

Seq Description Document Type Size
1 10-K capforceinc_10k.htm   iXBRL 10-K 1606060
2 EXHIBIT 21.1 capforceinc_ex21-1.htm EX-21.1 5870
3 EXHIBIT 23.1 capforceinc_ex23-1.htm EX-23.1 3984
4 EXHIBIT 31.1 capforceinc_ex31-1.htm EX-31.1 17550
5 EXHIBIT 32.1 capforceinc_ex32-1.htm EX-32.1 8370
  Complete submission text file 0001829126-26-005672.txt   7522457

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE opgn-20251231.xsd EX-101.SCH 62325
7 XBRL CALCULATION FILE opgn-20251231_cal.xml EX-101.CAL 66267
8 XBRL DEFINITION FILE opgn-20251231_def.xml EX-101.DEF 240017
9 XBRL LABEL FILE opgn-20251231_lab.xml EX-101.LAB 439717
10 XBRL PRESENTATION FILE opgn-20251231_pre.xml EX-101.PRE 377639
85 EXTRACTED XBRL INSTANCE DOCUMENT capforceinc_10k_htm.xml XML 1091345
Mailing Address 9717 KEY WEST AVENUE SUITE 100 ROCKVILLE MD 20850
Business Address 9717 KEY WEST AVENUE SUITE 100 ROCKVILLE MD 20850 301-869-9683
CapForce Inc. (Filer) CIK: 0001293818 (see all company filings)

EIN.: 061614015 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-37367 | Film No.: 261020614
SIC: 8071 Services-Medical Laboratories
(CF Office: 08 Industrial Applications and Services)